US equities
|
MU
$928.76
▲+0.00%
SNDK
$1,304.84
▲+0.00%
SKHY
$145.36
▲+0.00%
TSLA
$407.46
▲+0.00%
NVDA
$217.94
▲+0.00%
GOOGL
$320.58
▲+0.00%
INTC
$93.74
▲+0.00%
STX
$667.85
▲+0.00%
MU
$928.76
▲+0.00%
SNDK
$1,304.84
▲+0.00%
SKHY
$145.36
▲+0.00%
TSLA
$407.46
▲+0.00%
NVDA
$217.94
▲+0.00%
GOOGL
$320.58
▲+0.00%
INTC
$93.74
▲+0.00%
STX
$667.85
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Carlsmed, Inc. - Common Stock
(NQ:
CARL
)
15.42
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Carlsmed, Inc. - Common Stock
< Previous
1
2
Next >
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
From
Carlsmed
Via
GlobeNewswire
Carlsmed Inc (NASDAQ:CARL) Reports Q3 2025 Revenue Beat and Raises Full-Year Guidance
↗
November 06, 2025
Carlsmed (CARL) reported strong Q3 2025 results, beating revenue and EPS estimates with 98% YoY growth. The AI spine surgery firm also raised its full-year revenue guidance.
Via
Chartmill
Topics
Artificial Intelligence
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance
November 06, 2025
From
Carlsmed
Via
GlobeNewswire
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025
October 23, 2025
From
Carlsmed
Via
GlobeNewswire
< Previous
1
2
Next >